Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by Garp1on Mar 23, 2016 5:24am

165 Views

Post# 24691181

TH lifted to OTC Pink Current tier

Theratechnologies Inc. (THERF: OTC Pink No Information) | Tier Change Wed, Mar 23, 2016 12:00 - Theratechnologies Inc. ( THERF : OTC Pink No Information) - Tier Change - The symbol, THERF, no longer is classified as OTC Pink No Information. As of Wed, Mar 23, 2016, THERF resides in the OTC Pink Current tier

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading